In ADNI, differential gene expression analysis showed that expression levels of APH1B significantly increased in AD compared to CN (Supplementary Table 3) after adjusting for multiple testing, and this finding was replicated in AddNeuroMed (Fig. 1). The gene discussed is APH1B; the disease is Alzheimer disease.